# US 2025/0152890 A1 · Patient interface

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0152890 A1
- Document ID: US20250152890A1
- Status: Published application
- Kind: A1
- Application number: 18/555,958
- Filed: 2022-04-29
- Published: 2025-05-15
- Earliest claimed: 2021-04-30
- Assignees: Fisher & Paykel Healthcare Limited
- Applicants: Fisher & Paykel Healthcare Limited
- Inventors: Maximilian Ichabod PINKHAM; Enrico Alvarez GARCIA; Andre VAN SCHALKWYK; Kevin Peter O'DONNELL; Stanislav TATKOV
- Web page: https://patentgrep.com/patent/US20250152890A1

## CPC

- A61M 16/0666: {Nasal cannulas or tubing (devices for improving normal breathing through the nose A61F5/08; nose filters A62B23/06; outside holding devices A61M25/02)}
- A61M 16/0672: {Nasal cannula assemblies for oxygen therapy}
- A61M 16/024: {including calculation means, e.g. using a processor}
- A61M 16/0683: {Holding devices therefor}
- A61M 16/0875: {Connecting tubes}
- A61M 16/1005: {with O2 features or with parameter measurement}
- A61M 16/1095: {in the connecting tubes}
- A61M 16/125: {Diluting primary gas with ambient air}
- A61M 16/14: by mixing different fluids, one of them being in a liquid phase
- A61M 16/16: Devices to humidify the respiration air {(A61M16/1045 takes precedence)}
- A61M 16/202: {electrically actuated}
- A61B 5/14551: {for measuring blood gases}
- A61B 5/4836: {Diagnosis combined with treatment in closed-loop systems or methods (A61B5/0036 takes precedence)}
- A61B 5/6816: {Ear lobe}
- A61B 5/6826: {Finger}
- A61M 11/00: Sprayers or atomisers specially adapted for therapeutic purposes (in general B05B; {aerosol containers B65D83/14})
- A61M 16/0051: {with alarm devices}
- A61M 16/0066: {Blowers or centrifugal pumps}
- A61M 16/0816: {Joints or connectors}
- A61M 16/109: {the humidifying liquid or the beneficial agent}
- A61M 16/161: {with means for measuring the humidity}
- A61M 2016/0027: {pressure meter}
- A61M 2016/0039: {in the inspiratory circuit}
- A61M 2016/1025: {the O2 concentration}
- A61M 2202/0007: introduced into the body
- A61M 2202/02: Gases
- A61M 2202/0208: Oxygen
- A61M 2202/0225: Carbon oxides, e.g. Carbon dioxide
- A61M 2202/025: Helium
- A61M 2202/0266: Nitrogen (N)
- A61M 2202/0275: Nitric oxide [NO]
- A61M 2205/02: characterised by a particular materials
- A61M 2205/0266: Shape memory materials
- A61M 2205/3331: Pressure; Flow
- A61M 2205/3334: Measuring or controlling the flow rate
- A61M 2205/3368: Temperature
- A61M 2205/3379: Masses, volumes, levels of fluids in reservoirs, flow rates
- A61M 2205/3553: remote, e.g. between patient's home and doctor's office
- A61M 2205/3569: sublocal, e.g. between console and disposable
- A61M 2205/3592: using telemetric means, e.g. radio or optical transmission
- A61M 2205/42: Reducing noise
- A61M 2205/505: Touch-screens; Virtual keyboard or keypads; Virtual buttons; Soft keys; Mouse touches
- A61M 2205/584: having a color code
- A61M 2206/10: Flow characteristics
- A61M 2207/00: Methods of manufacture, assembly or production
- A61M 2209/08: Supports for equipment
- A61M 2210/0618: Nose
- A61M 2230/06: Heartbeat rate only
- A61M 2230/205: partial oxygen pressure (P-O2)
- A61M 2230/42: Rate
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)

## Abstract

A nasal interface 100 has a cannula body 118 with a first prong 111 and a second prong 112. The first prong 111 and the second prong 112 are asymmetrical to each other. A gases manifold 120 has a gases inlet 121. The first prong 111 and the second prong 112 are in fluid communication with the gases inlet 121. The gases manifold 120 is reconfigurable relative to the cannula body 118 between a first configuration and a second configuration. The first configuration corresponds to the gases manifold 120 being inserted into the cannula body 118 from a first side. The second configuration corresponds to the gases manifold 120 being inserted into the cannula body 118 from a second side.

## Claims

### Claim at position 1

1-51. (canceled)

### Claim 52

A nasal interface comprising:
a first prong and a second prong that are asymmetrical to each other;
a gases manifold comprising a gases inlet;
wherein the first prong and the second prong are in fluid communication with the gases inlet;
wherein the nasal interface is configured to cause an asymmetrical flow of gases at a patient's nares; and
wherein the nasal interface is configured such that at least 60% of a total volumetric flow rate of gases flow into the gases inlet is delivered out of the nasal interface through the first prong.

### Claim 53 (depends on 52)

The nasal interface of claim 52 wherein the nasal interface is configured such that between 60% and 80% of a total volumetric flow rate of gases flow into the gases inlet is delivered out of the nasal interface through the first prong when the total volumetric flow rate of gases flow into the gases inlet is between 5 liters per minute (lpm) and 70 lpm.

### Claim 54 (depends on 52)

The nasal interface of claim 52 further comprising a gases flow path from the gases inlet to the first prong and the second prong, wherein a first prong inner cross-sectional area of the first prong is larger in a direction transverse to gases flow through the first prong than a second prong inner cross-sectional area of the second prong.

### Claim 55 (depends on 54)

The nasal interface of claim 54, wherein the direction transverse to gases flow is substantially perpendicular or normal to gases flow through the first prong and the second prong.

### Claim 56 (depends on 54)

The nasal interface of claim 54, wherein the first prong inner cross-sectional area is positioned at an outlet of the first prong and a second prong inner cross-sectional area is positioned at an outlet of the second prong.

### Claim 57 (depends on 52)

The nasal interface of claim 52, wherein the nasal interface comprises a cannula body comprising the first prong and the second prong.

### Claim 58 (depends on 57)

The nasal interface of claim 57, comprising a gases manifold, wherein the gases manifold is integral with the cannula body or is separate from and couplable with the cannula body.

### Claim 59 (depends on 58)

The nasal interface of claim 58, wherein the nasal interface comprises a face mount part, and wherein the first prong and the second prong comprise a pair of asymmetrical tubular nasal prongs, integrally moulded with or removably attached to the face mount part.

### Claim 60 (depends on 59)

The nasal interface of claim 59, wherein the face mount part comprises at least one substantially horizontal side entry passage to an interior of a base portion or cannula body of the face mount part for releasably receiving an outlet of the gases manifold therethrough.

### Claim 61 (depends on 60)

The nasal interface of claim 60, wherein the face mount part comprises a pair of opposed side entry passages to the interior of the base portion or cannula body, each adapted to releasably receive the outlet of the gases manifold therethrough.

### Claim 62 (depends on 59)

The nasal interface of claim 59, wherein the gases manifold is insertable into the face mount part, or wherein the gases manifold is insertable into the face mount part from either of two opposing horizontal directions.

### Claim 63 (depends on 59)

The nasal interface of claim 59, wherein the gases manifold is formed from a relatively harder material and the face mount part provides a soft interfacing component to a patient, wherein the gases manifold fluidly couples a conduit to the first prong and the second prong of the face mount part.

### Claim 64 (depends on 52)

The nasal interface of claim 52, wherein the first prong and second prong are configured to engage with nasal passages of a patient in an unsealed manner and/or wherein the first prong and the second prong allow exhaled gases to escape around the first prong and the second prong.

### Claim 65 (depends on 52)

The nasal interface of claim 52, wherein the first prong and the second prong are configured to provide gases to a patient without interfering with a patient's spontaneous respiration.

### Claim 66 (depends on 52)

The nasal interface of claim 52, wherein the first prong and the second prong are curved to extend into a patient's nares in use and to provide a smooth flow path for gases to flow through, and/or inner surfaces of the first prong and the second prong are contoured to reduce noise, and/or bases of the first prong and the second prong include curved surfaces to provide for smoother gases flow, and/or the first prong and the second prong are substantially hollow and substantially tubular in shape, and/or the first prong and the second prong are consistent in diameter along their lengths or alternatively are shaped to fit contours of nares of a patient, and/or a face mount part is shaped to generally follow contours of a patient's face around an upper lip area, and/or the face mount part is molded or pre-formed to be able to conform to and/or is pliable to adapt, accommodate and/or correspond with contours of a patient's face in a region of the patient's face where the nasal interface is to be located.

### Claim 67 (depends on 54)

The nasal interface of claim 54, wherein a ratio of the first prong inner cross-sectional area to the second prong inner cross-sectional area is between 60:40 and 80:20; or between 65:35 and 80:20; or between 70:30 and 80:20; or between 70:30 and 75:25; or 70:30, 71:29, 72:28, 73:27, 74:26, or 75:25; or between 75:25 and 80:20; or 75:25, 76:24, 77:23, 78:22, 79:21, or 80:20.

### Claim 68 (depends on 54)

The nasal interface of claim 54, wherein the gases flow path is defined by a flow channel that has a gases flow direction that is substantially perpendicular to gases flow paths through the first prong and the second prong, and wherein the first prong is more distal the gases inlet and the second prong is more proximal the gases inlet.

### Claim 69 (depends on 68)

The nasal interface of claim 68, wherein the nasal interface comprises a cannula body comprising the first prong and the second prong, wherein the nasal interface comprises a gases manifold, wherein the gases manifold is integral with the cannula body or is separate from and couplable with the cannula body, wherein a first section of the flow channel in the gases manifold has a first large vertical dimension, an opposite end of the flow channel forms a flow cavity in the cannula body that delivers gases to the first prong and the second prong, the flow cavity is in fluid communication with flow passages through the first prong and the second prong when the gases manifold is in position in the cannula body, and wherein at least part of the flow cavity has a vertical dimension that is smaller than a first vertical dimension.

### Claim 70 (depends on 69)

The nasal interface of claim 69, wherein the gases manifold comprises one or more internal angled walls to provide a reduction in dimensions from the first vertical dimension to the vertical dimension that is smaller than the first vertical dimension and to direct the gases flow into the first prong and/or the second prong.

### Claim 71 (depends on 52)

The nasal interface of claim 52, wherein a flow path of the first prong and a flow path of the second prong are unobstructed.

### Claim 72 (depends on 52)

The nasal interface of claim 52, wherein the nasal interface is configured such that between 65% and 80% of the total volumetric flow rate of gases flow into the gases inlet is delivered out of the nasal interface through the first prong, or such that between 70% and 80% of the total volumetric flow rate of gases flow into the gases inlet is delivered out of the nasal interface through the first prong, or such that between 70% and 75% of the total volumetric flow rate of gases flow into the gases inlet is delivered out of the nasal interface through the first prong, or such that 70% of the total volumetric flow rate of gases flow into the gases inlet is delivered out of the nasal interface through the first prong, or such that between 75% and 80% of the total volumetric flow rate of gases flow into the gases inlet is delivered out of the nasal interface through the first prong, or such that 75% of the total volumetric flow rate of gases flow into the gases inlet is delivered out of the nasal interface through the first prong, or such that 80% of the total volumetric flow rate of gases flow into the gases inlet is delivered out of the nasal interface through the first prong.

### Claim 73 (depends on 52)

The nasal interface of claim 52, wherein the gases inlet is in fluid communication with a breathable tube.

### Claim 74 (depends on 73)

The nasal interface of claim 73, wherein water vapour can pass through a wall of the breathable tube, but liquid water and a bulk flow of gases cannot flow through the wall of the breathable tube.

### Claim 75 (depends on 52)

The nasal interface of claim 52, wherein the nasal interface comprises a cannula body comprising the first prong and the second prong, and comprises a gases manifold, wherein the gases manifold is reconfigurable relative to the cannula body between a first configuration and a second configuration, wherein the first configuration corresponds to the gases manifold being inserted into the cannula body from a first side of the cannula body such that the second prong is more proximal the gases inlet and the first prong is more distal the gases inlet, and the second configuration corresponds to the gases manifold being inserted into the cannula body from a second side of the cannula body such that the first prong is more proximal the gases inlet and the second prong is more distal the gases inlet.

### Claim 76 (depends on 52)

The nasal interface of claim 52, wherein the first prong and the second prong are asymmetrical to each other and/or are not symmetrical to each other and/or differ in shape and configuration to each other and/or are asymmetrical when compared to each other.
